Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 3

Sponsor Class

INDUSTRY 3OTHER 2OTHER_GOV 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Melanoma 3Colitis, Ulcerative 3Inflammatory Bowel Diseases 2Crohn Disease 2Pancreatic Neoplasms 1Lymphoma 1Lung Neoplasms 1Hepatitis 1Graft vs Host Disease 1Colitis 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Bronchiolitis Obliterans Syndrome 1Arthritis, Rheumatoid 1Anorexia 1Anemia 1

Interventions

etrolizumab 5Infliximab 3Adalimumab 2peficitinib 1golimumab 1NX-13 1Methylprednisolone 1Mesalamine 1Injections 1CT-P13 1Andrographis paniculata extract 1ABX464 12-(3',4'-dihydroxyphenyl-1-azo)benzimidazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Colitis, Ulcerative × Infliximab × Clear all
NCT01804166 2025-02-04

A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)

Janssen Scientific Affairs, LLC

Phase 4 Completed
1 enrolled 1 chart
Lymphoid

Colitis, Ulcerative, Crohn Disease, Lymphoma, Inflammatory Bowel Diseases

NCT02136069 2021-12-03

GARDENIA

Hoffmann-La Roche

Phase 3 Completed
397 enrolled 32 charts

Colitis, Ulcerative

NCT03452501 2021-02-23

Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients

Hikma Pharmaceuticals LLC

Completed
157 enrolled

Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡